A Woburn biotech behind antibodies for Covid-19, cancer and eye disease is set to go public by reverse-merging with a special-purpose acquisition company, or SPAC.
A Woburn biotech behind antibodies for Covid-19, cancer and eye disease is set to go public by reverse-merging with a special-purpose acquisition company, or SPAC.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.